who we are
Dedicated to results
The NellOne Therapeutics is passionate about its work to pioneer advances in the field of tissue regeneration, developed over the course of many years of scientific research and exploration. Our highly experienced team is committed to improving outcomes for millions of patients across the world, and creating a successful business that truly makes a difference.
Serial entrepreneur Bill Malkes was appointed Chief Executive Officer of NellOne Therapeutics in April 2020. He previously co-founded and led GRIDSMART Technologies Inc, a global intelligent transportation solutions business, which was sold for $87 million in 2019. Under Malkes’ leadership, the business grew to be the second largest in its space, and expanded to 22 countries around the world. Prior to GRIDSMART, Malkes held a number of senior leadership and advisory roles in technology and healthcare businesses including Health Care Solutions, ASIC International, Tradewind Technologies and Learning Technology Systems.
A servant leader at heart and builder of all things, Bill strives to leave things bigger and better than when he found them. To learn more about our CEO, visit billmalkes.com.
An investor, executive, and entrepreneur, Ms. Warren co-founded NellOne Therapeutics, a soft-tissue regenerative medicine company based on the NELL1 gene based on work initiated at Oak Ridge National Laboratory by her co-founder, Dr. Cymbeline Culiat. As founding CEO, she leads the company’s efforts with respect to strategy, fundraising, business development and licensing for its equine and human therapies.
Having spent over a decade commercializing technologies from nation’s leading institutions, Tracy serves on the Boards of Children’s Research Institute (CRI) at Children’s National Medical Center (Washington, DC) and Clemson University Research Foundation, and is a member of the Business Advisory Council to the Sheikh Zayed Institute for Pediatric Surgical Innovation. In addition to her investment activities, she also provides early-stage leadership to other businesses, currently serving as a general partner of Astarte Ventures, an early stage venture firm focused exclusively on women’s and children’s health and wellbeing.
Partner with us
Join us in plotting a new future for regenerative medicine, and help us in our work to revolutionize the treatment of major traumatic wounds in soft tissue.